Exploration on anti-hypoxia properties of peptides: a review

F Yang, T Xie, Z Hu, Z Chu, H Lu, Q Wu… - Critical Reviews in …, 2023 - Taylor & Francis
Peptides are important components of human nutrition and health, and considered as safe,
nontoxic, and easily absorbed potential drugs. Anti-hypoxia peptides are a kind of peptides …

Myeloid-derived suppressor cells in transplantation and cancer

JC Ochando, SH Chen - Immunologic research, 2012 - Springer
Myeloid-derived suppressor cells (MDSC) are myeloid cells that suppress the immune
response, a definition that reflects both their origin and their function. As negative regulators …

Hypoxia as a target for tissue specific gene therapy

T Rhim, DY Lee, M Lee - Journal of Controlled Release, 2013 - Elsevier
Hypoxia is a hallmark of various ischemic diseases such as ischemic heart disease,
ischemic limb, ischemic stroke, and solid tumors. Gene therapies for these diseases have …

The fate of allogeneic pancreatic islets following intraportal transplantation: challenges and solutions

X Li, Q Meng, L Zhang - Journal of immunology research, 2018 - Wiley Online Library
Pancreatic islet transplantation as a therapeutic option for type 1 diabetes mellitus is gaining
widespread attention because this approach can restore physiological insulin secretion …

Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice

X Zhang, T Cui, J He, H Wang, R Cai… - Proceedings of the …, 2015 - National Acad Sciences
Agonists of growth hormone-releasing hormone (GHRH) have been previously reported to
promote growth, function, and engraftment of islet cells following transplantation. Here we …

Local, controlled release in vivo of vascular endothelial growth factor within a subcutaneous scaffolded islet implant reduces early islet necrosis and improves …

JA Gebe, A Preisinger, MD Gooden… - Cell …, 2018 - journals.sagepub.com
Islet transplantation remains the only alternative to daily insulin therapy for control of type 1
diabetes (T1D) in humans. To avoid the drawbacks of intrahepatic islet transplantation, we …

Reversal of diabetes in mice with a bioengineered islet implant incorporating a type I collagen hydrogel and sustained release of vascular endothelial growth factor

RB Vernon, A Preisinger, MD Gooden… - Cell …, 2012 - journals.sagepub.com
We have developed a bioengineered implant (BI) to evaluate strategies to promote graft
survival and function in models of islet transplantation in mice. The BI, sized for implantation …

Stem cells: a renewable source of pancreatic β-cells and future for diabetes treatment

S Kh, KH Haider - Stem cells: latest advances, 2021 - Springer
According to the figures released by the International Diabetes Federation (IDF), there were
more than 4.8 million diabetes-related deaths in 2012 alone, and a total of 371 million …

Pancreatic islet transplantation in type 1 diabetes mellitus: an update on recent developments

A Ramesh, P Chhabra, KL Brayman - Current diabetes reviews, 2013 - ingentaconnect.com
Type 1 diabetes mellitus is an autoimmune disease that is characterized by the destruction
of the islets of Langerhans cells which produce insulin. The current gold standard treatment …

3D printed VEGF-CPO biomaterial scaffold to promote subcutaneous vascularization and survival of transplanted islets for the treatment of diabetes

X Chen, K Wang, Y Han, Q Pan, X Jiang, Z Yu… - International Journal of …, 2024 - Elsevier
Diabetes is a complex metabolic disease and islet transplantation is a promising approach
for the treatment of diabetes. Unfortunately, the transplanted islets at the subcutaneous site …